Also known as آسٹیوپوروسس مینجمنٹ
Consultant Physician
M.B.B.S., F.C.P.S., MACP ( USA), FPSIM (PAK), RCP London (UK)
Consultant Physician
M.B.B.S., F.C.P.S., MACP ( USA), FPSIM (PAK), RCP London (UK)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MCPS (Medicines)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), Fellowship Endocrinology
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), Fellowship Endocrinology
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S.
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Internal Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.(Medicine), M.C.P.S
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
M.B.B.S., F.C.P.S. ( MEDICINE )
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Nephrology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures